Notice Number: NOT-AI-16-052
Key Dates
Release Date: May 16, 2016
Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
Purpose
The purpose of this Notice is to inform potential applicants of the National Institute of Allergy and Infectious Diseases (NIAID) participation, effective immediately, in the Funding Opportunity Announcement (FOA), PA-16-183, entitled "Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (Admin Supp)" limited to U01 applications only.
PA-16-183 has been updated in the following ways to reflect NIAID's participation in this FOA.
93.350, 93.855, 93.856, 93.847, 93.846
All other aspects of the FOA remain the same.
Inquiries
Please direct all inquiries to:
Michael Minnicozzi, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Phone: 301-496-7074
Email: minnicozzim@niaid.nih.gov